Robert Redfield
CIK: 0002018274
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Traws Pharma, Inc.
Discretionary Trading P&L
Holdings
Transaction History (4 total)
- Jul 9, 2026TRAW
Traws Pharma, Inc.
Award(A)DirectStock Option (right to buy)
84K shares- - Mar 8, 2026TRAW
Traws Pharma, Inc.
Award(A)DirectStock Option (right to buy)
108.9K shares- - Dec 12, 2025TRAW
Traws Pharma, Inc.
Award(A)Direct16.4K shares- - Oct 12, 2025TRAW
Traws Pharma, Inc.
Award(A)DirectStock Option (right to purchase)
32.4K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jul 9, 2026 | TRAW Traws Pharma, Inc. | Award(A) Stock Option (right to buy) | 84,000 | - | - | Direct |
| Mar 8, 2026 | TRAW Traws Pharma, Inc. | Award(A) Stock Option (right to buy) | 108,854 | - | - | Direct |
| Dec 12, 2025 | TRAW Traws Pharma, Inc. | Award(A) | 16,419 | - | - | Direct |
| Oct 12, 2025 | TRAW Traws Pharma, Inc. | Award(A) Stock Option (right to purchase) | 32,406 | - | - | Direct |
1-4 of 4 transactions
About Redfield Robert
Redfield Robert (SEC CIK 0002018274) files insider reports with the SEC as Chief Medical Officer of Traws Pharma, Inc. (TRAW).
Signal8 holds 4 ownership filings by Redfield Robert, all Form 4s, filed between Oct 15, 2025 and Jul 14, 2026. Those filings report 4 transactions, from Oct 12, 2025 to Jul 9, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Redfield Robert's filings is in NEWTOWN, PA.
Recent filings by Redfield Robert
Other insiders filing for Traws Pharma, Inc. (TRAW)
- Pauza Charles David, Chief Science Officer Virology
- CAUTREELS WERNER, Director
- Savchuk Nikolay, Chief Operating Officer
- STOVER JACK E, Director
- Dukes Iain D., Chief Executive Officer
- Parker Charles Nolan, Chief Financial Officer